# Efficacy and Safety of Retlirafusp Alfa Plus Bevacizumab and Chemotherapy With or Without Short-Course Radiotherapy in Patients With CRCLM

> clinical trial · VERIFIED · 2026-07-27

Status: NOT_YET_RECRUITING · Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology · Condition: CRC (Colorectal Cancer)

- Company: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07728019

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.